Media centre

Want to know about children and young people with cancer and their families? Well, we’ve got something to say! Our Media and PR team is available 24/7 for comment, interviews and information.

For media enquiries only, call our Media and PR team on +44 (0)20 8752 2812 or email mediarelations@clicsargent.org.uk (Please note, we are only able to help with media queries on this number, for anything else please call 0300 330 0803)

Out of hours contact: +44 (0)844 848 1189

You can also check out our contacts for journalists and our Ambassadors and Celebrity Supporters page.

“Sometimes we didn’t know how we were going to pay the mortgage at the end of the month” – Bradley Lowery’s mum Gemma opens up about impact of travel costs on families whose children have cancer

Wednesday 20 November 2019

In a heartfelt plea, Bradley Lowery’s mum Gemma, CEO of the Bradley Lowery Foundation, has backed CLIC Sargent’s call to all party leaders to commit to a Young Cancer Patient Travel Fund if they become the next Prime Minister.

Two young cancer survivors star in heart-warming surprise video as H. Samuel and Ernest Jones launch children’s teddy bear campaign for Christmas

Wednesday 13 November 2019

H. Samuel and Ernest Jones have launched their national fundraising campaign for Christmas with the help of two young cancer survivors to raise vital funds for CLIC Sargent, the UK’s leading charity for children and young people living with cancer.

Pebbles the CLIC Sargent Christmas bear

“We wiped out our savings within the first couple of months, everything we had was gone” – Travel costs leave families of young cancer patients struggling to afford basic essentials

Tuesday 12 November 2019

Parents of young cancer patients are struggling to keep a roof over their heads or heat their homes because of the huge cost of taking their child to hospital for life-saving treatment, new research from CLIC Sargent has revealed.

Southport pub team crowned national champions in five-a-side football fundraiser for CLIC Sargent

Thursday 7 November 2019

Staff from a J D Wetherspoon pub in Southport crowned the best five-a-side team in annual Kick for CLIC tournament.

CLIC Sargent publishes its annual Impact and Accountability Report – The Good, The Bad and The Ugly

Tuesday 29 October 2019

CLIC Sargent has today published its latest Impact and Accountability Report – The Good, The Bad and The Ugly, detailing an overview of the charity’s finances, money spent and vital reach of services.

New research published by CLIC Sargent reveals that nearly half of young cancer patients are more worried about debt since their diagnosis

Tuesday 15 October 2019

Research published by CLIC Sargent looking into the banking experiences of young people with cancer has revealed that nearly half (44%) are more worried about borrowing money and debt since being diagnosed.

CLIC Sargent launches ‘Player vs Cancer’ so gamers can now raise funds and awareness

Monday 14 October 2019

CLIC Sargent has today launched a new fundraising campaign, Player vs Cancer, so gamers in the UK and around the world can now raise vital funds for the charity.  

Sutton charity awards night for young people with cancer who defied the odds in their education

Wednesday 9 October 2019

The Youth Achievement Awards, hosted by CLIC Sargent at the the Royal Marsden Hospital, recognised young people for academic achievement while going through cancer treatment.

Metcalfe’s® raises more than £100,000 to support children and young people with cancer

Tuesday 24 September 2019

Popular snack brand Metcalfe’s® has raised more than £100,000 through popcorn sales for partner charity CLIC Sargent.

CLIC Sargent responds to news that children are being denied new cancer drugs

Friday 20 September 2019

A study from the Institute of Cancer Research and The Royal Marsden NHS Foundation Trust has shown the power of genetic testing to pick out potential new treatments for children with cancer to extend and improve their lives. However, only 7% of children could access appropriate drugs, partly due to regulatory and funding barriers, and lack of access to clinical trials.